AtriCure
ATRC
201 hedge funds and large institutions have $1.6B invested in AtriCure in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 78 increasing their positions, 72 reducing their positions, and 35 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 72
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $1.62B → $1.6B (-$21.9M)
4.19% less ownership
Funds ownership: 103% → 98.81% (-4.2%)
9% less funds holding
Funds holding: 221 → 201 (-20)
51% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$106M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$22.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.23M |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$4.36M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$4.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
-$32.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$23.5M |
| 3 |
Jennison Associates
New York
|
-$19.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$18M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$14.4M |
ATRC Hedge Fund Activity: Q2 2025 in Review
201 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2025, worth a combined $1.6B — down 1.3% from $1.62B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of ATRC and 17 opened new positions — a net loss of 18 holders — while 72 trimmed existing stakes and 78 added.
The largest buyer was Wellington Management Group, adding an estimated $106M. The largest seller was UBS AM, cutting an estimated $32.3M.
- 201 institutional investors held AtriCure (ATRC) as of Q2 2025, down from 221 in Q1 2025.
- Funds reported $1.6B of AtriCure stock for Q2 2025, down 1.3% quarter-over-quarter.
- 17 funds opened new AtriCure positions in Q2 2025 and 35 closed out, a net change of -18 holders.
- The largest AtriCure buyer in Q2 2025 was Wellington Management Group, an estimated $106M added.
- The largest AtriCure seller in Q2 2025 was UBS AM, an estimated $32.3M sold.
Based on aggregated 13F filings for Q2 2025.